Stephen Y Chui Selected Research

Stephen Y Chui Research Topics

10	Triple Negative Breast Neoplasms 09/2022 - 07/2016
10	Neoplasms (Cancer) 09/2022 - 01/2004
7	Breast Neoplasms (Breast Cancer) 12/2021 - 07/2015
3	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2018
2	Pathologic Complete Response 09/2022 - 01/2020
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2021
1	Pneumonia (Pneumonitis) 10/2020
1	Melanoma (Melanoma, Malignant) 10/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020
1	Carcinoma (Carcinomatosis) 10/2020
1	Neutropenia 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Fatigue 01/2020
1	Autoimmune Hepatitis 01/2020
1	Liver Failure 01/2020
1	Disease Progression 11/2018
1	Residual Neoplasm 07/2016
1	Stomach Neoplasms (Stomach Cancer) 08/2005

8	atezolizumabIBA 09/2022 - 11/2018
8	130-nm albumin-bound paclitaxelIBA 09/2022 - 11/2018
4	B7-H1 AntigenIBA 12/2021 - 11/2018
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 07/2016
4	taxaneIBA 01/2021 - 11/2018
4	Hormones (Hormone)IBA 01/2020 - 07/2016
3	Trastuzumab (Herceptin)FDA Link 12/2021 - 07/2015
2	Carboplatin (JM8)FDA LinkGeneric 12/2021 - 07/2016
2	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2020
2	human ERBB2 proteinIBA 11/2018 - 07/2016
1	ErbB Receptors (EGF Receptor)IBA 12/2021
1	pertuzumabIBA 12/2021
1	Docetaxel (Taxotere)FDA Link 12/2021
1	Ado-Trastuzumab EmtansineIBA 12/2021
1	LigandsIBA 10/2020
1	AnthracyclinesIBA 10/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020
1	cyclopropapyrroloindoleIBA 10/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2019
1	neratinibIBA 07/2016
1	veliparibIBA 07/2016
1	Drug CombinationsIBA 07/2015
1	Tyrosine Kinase InhibitorsIBA 07/2015
1	Lapatinib (GW572016)FDA Link 07/2015
1	VaccinesIBA 08/2005